Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Have you tried getting a doctors appointment recently Alamo ?
I would far rather know in 5 minutes than 5 weeks .
Time to top up on the Guinness and a spot of sun bathing whilst you wait .
Well the scenario goes like this.......
You wake up one morning felling extra tired even though you've had a good night's sleep, it continues for a further three nights and during the day as well. At the end of the week you think you have a problem so you phone the doctor, he decides you might be short of vit d or iron so he advised you to come in for a blood test to find out.
Or......you decide for yourself that you are short of vit d or iron because of extra tiredness, not 100% sure but you're in Boots and you see a self test and decide to buy. If you're not deficient you've wasted your hard earned, then your mate tells you that the doc would have done that for free!
So.....which scenario makes sense? Use your common hear!
Alamo55: Maybe because you can walk into Boots whenever you like and have a test in your hand in five minutes. The alternative is to 'make an appointment with your GP' (wahahahaha) - if you have one and if you can get an appointment - and maybe that appointment when you have finally persuaded the receptionist you really want/need one wont be too many weeks/months away!?
I do have an ignorant question….
Is it the case that we are simply providing our own Vitamin D and Iron tests to Boots for them to White Label. I’m assuming so given that Yates has confirmed we’re fulfilling material production orders during H2 24. Great if that is the case
.....why would anybody buy a self test for iron or vit d deficiency when you can get one on the NHS for free? Makes no sense unless people don't realise.
Any guess as to what our profit margin is on each test. We still got a long way to go to satisfy a share price equivalent to when the company went on AIM.
Yep great new , not many of my aim shares apart from this one I am positive about at the moment .
Looks like the smart strategic planning by the BOD over the last couple of years is finally paying off. Excellent news.
Phew...only 3 years time and not over 18,000 as I read it :)
Brilliant news!
Pleased I've been topping up, it's a no brainer.
Only share I'm confident in to invest long term at the minute.
Just goes to highlight the very wide broad and diverse mix of revenue opportunities now available to ABDX arising out of general LFT awareness, massive leaps in tech, and the extensive customer base it’s steadily built despite a few years of painful cost control. Well done to the BOD.
Yup, and there’s a very fair chance that Boots will look to further expand their self test offerings in future. Great new relationship.
Excellent news - ABDX seems on a roll now.
Well apart from anything, it gives us a foothold with the largest U.K. pharmacy brand, which is great for us and surely must be attractive to any potential CRO/CDMO partner ultimately looking to commercialise through the retail self test market.
So that’s now Boots, Tesco, and Superdrug we have relations with. Not bad. Not bad at all.
I get the feeling that's just the start.
If that doesn't move the SP north nothing will..
ABDX confirm launch of OEM self-tests in Boots
* Boots to sell its first own brand self-tests in stores and online across the UK provided by Abingdon Health
* The global lateral flow assay market size is expected to reach USD $23 billion by 2027.
More positive news from ABDX....
Good luck, Brighty
Very nice surprise - wasn’t expecting it to be Boots!
A bit more on VenomAid and their plans to now initiate manufacturing
https://www.venomaid.com/news/venomaid-extends-its-seed-round-to-a-total-of-1-8-m-for-affordable-and-rapid-snakebite-diagnostics
Another potential one, borne purely out of mutual reactions I’ve noticed between VenomAid Diagnostics and Yates for some time. Founded in 2018 they spent a few years developing a test for Snakebite, and in 2023 attracted $1.8m seed funding to accelerate development to market and clinical testing. That is when all the reactions started and it’s not much of a leap to think some of the seed money came, and may still be coming our way.
https://www.venomaid.com/
Latest LinkedIn post Yates liked
https://www.linkedin.com/posts/venomaid_phdoftheyear-snakebite-impact-activity-7175741991522091009-jBbP?utm_source=share&utm_medium=member_desktop
Further interesting post and comment from our Liam Currivan today regarding Eco-Flo
https://www.linkedin.com/posts/liam-currivan-8bab88135_heriot-watt-university-creates-lateral-flow-activity-7175735834115985408-xiTu?utm_source=share&utm_medium=member_desktop
In case anyone missed it by the way, at about 2.43 in the pitch link I gave earlier in this thread, LVOne talk about how their test might be priced, saying “LVOne could be sold at a maximum of £620 and still be cost effective to the U.K. Healthcare system NHS.”
Now whether or not that’s anywhere close to final pricing is anyone’s guess, and so would be our % cut as manufacturer, but talking of many hundreds of pounds for a single test gives an idea of revenue potential here. Remember, the real value of LVOne is in the massive long term cost saving resulting from earlier, even 90 minute earlier, diagnosis, and that may well be worth the NHS shelling out that kind of money. And not to forget, NHS leaders were on the panel that chose Upfront as winners.
Again just for info but a company called NordicDx, which develops aquaculture tests to monitor fish health (presumably in farms) put this out today.
https://www.linkedin.com/posts/tommy-selnes-101a9653_nordicdx-revolusjonerende-teknologi-for-activity-7175375881006104576-vdUW?utm_source=share&utm_medium=member_desktop
As you will see, it’s in Norwegian and completely innocuous, but despite that both Chris Yates and our sales Director, Liam Currivan liked it. It relates to this article which describes a new digital reader for their LFT
https://nordicdx.no/en/nordicdx-no-innovativ-fiskehelseovervaking-digitalisering-hurtigtester-lfa/
I can’t think of any reason why both these ABDX guys would react to it unless we were somehow involved. Could be wrong.
Just for info but ABDX posted a job advert for a full time Supply Chain Assistant at the beginning of the month, and for a Part Time Buyer within the supply chain yesterday
https://www.google.com/search?q=jobs+at+abingdon+health&rlz=1C1BFEM_en-gbGB1004GB1004&oq=jobs+at+abingdon+health&gs_lcrp=EgZjaHJvbWUyBggAEEUYOTIHCAEQIRigATIHCAIQIRigATIHCAMQIRigATIHCAQQIRifBTIHCAUQIRifBTIHCAYQIRifBTIHCAcQIRifBTIHCAgQIRifBTIHCAkQIRifBdIBCDU2ODNqMGo0qAIAsAIA&sourceid=chrome&ie=UTF-8&ibp=htl;jobs&sa=X&ved=2ahUKEwihrteZrv6EAxUFS0EAHV7fBVMQkd0GegQIEBAB#fpstate=tldetail&htivrt=jobs&htiq=jobs+at+abingdon+health&htidocid=u_H6W8dAPmMquULfAAAAAA%3D%3D
What exactly is behind this is anyone's guess, but both roles seem geared to the manufacturing arm of the business so it could relate to improved Salistick sales, the new OEM contract orders Yates has told us about, something else, or it could just be he's replacing staff that have left!
Pretty mundane stuff I know, but always good to be aware of these things.
Another quiet day...
The only thing that's interesting is that all but one of the transactions today have been sells, yet each of those sells was transacted at a higher price than the last. So the actual bid is rising even though all we are seeing is sells.
And I noticed in the auction this morning that we had two Direct Market Access offers for stock, one for 100,000 at 8.5, and the other at 7999 at 9.
So I am wondering if these two things might indicate a sizeable buy order in the background, although I freely admit that's outside of my competence so would appreciate any insights others might give.
We just have to be patient. Its undervalued - hopefully partnerships/orders will drive the sp up. Right now there is a lack of awareness of this stock or people have lost confidence over the years